TOMM40/FADS2 Expression Ratio Predicts the Sensitivity to mTOR Inhibitors in Triple‐Negative Breast Cancer
ABSTRACT Background Triple‐negative breast cancer (TNBC) is a subtype of breast cancer that lacks the expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor‐2 (HER2). There is a lack of predictive biomarkers for the response of patients with TNBC...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Wiley
2026-07-01
|
| Schriftenreihe: | Cancer Medicine |
| Schlagworte: | |
| Online-Zugang: | https://doi.org/10.1002/cam4.72089 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|